speb/financial-data huggingface dataset:
Financial ratios for ELAB — quarterly report dated 2025-09-30
Total revenue: 285948
Gross profit: 78030
Operating income: -2194727
Net income: -2594320
Capital expenditures: 95594
Operating cash flow: -1490167
Depreciation & amortization: 35284
Net tangible assets: 4982456
Owner earnings: -2654630
Return on net tangible assets (%): -53.27954727548021
Buffett classification: The Gruesome
Stock price: 126.96
Shares outstanding: 4543751
Book value: 8490655
P/B ratio: 67.94229973541499
Market cap (USD): 576874626.9599999
Debt to equity: 0.5192712458579462
Current ratio: 1.789304669688441
Quick ratio: 1.765782837992329
Interest coverage ratio: -126.1264869835067
COGS to revenue (%): 72.711821729825
R&D to revenue (%): 5.245709010029795
SG&A to revenue (%): 629.9190761956719
Free cash flow (dilution-adjusted): -1598940
Buyback yield (%): 0
Retained earnings: -18034757
Inventory turnover: 1.6184293487144759
Receivables turnover: 0.7740206587409861
Capitalized R&D asset: 70375.14
ROCI (R&D-adjusted, %): -23.23067379482249
FCF margin (%): -559.1715976331361
Rule of 40 score: -559.1715976331361
Financial ratios for ELAB — quarterly report dated 2025-12-31
Total revenue: 304136
Gross profit: 107284
Operating income: -2410864
Net income: -2982683
Capital expenditures: 346661
Operating cash flow: -1750000
Depreciation & amortization: 59757
Net tangible assets: 3967191
Owner earnings: -3269587
Return on net tangible assets (%): -82.41566892040237
Buffett classification: The Gruesome
Stock price: 35.52
Shares outstanding: 4543751
Book value: 7837362
P/B ratio: 20.592903009966875
Market cap (USD): 161394035.52
Debt to equity: 0.3374794988415745
Current ratio: 1.7429576571622223
Quick ratio: 1.7188351661062486
Interest coverage ratio: -10.493286268296822
COGS to revenue (%): 64.72499145119289
R&D to revenue (%): 10.818186600731252
SG&A to revenue (%): 620.6259699608071
Free cash flow (dilution-adjusted): -2107318
Buyback yield (%): 0
Retained earnings: -21017440
Inventory turnover: 2.0699909566973016
Receivables turnover: 0.8931227993927131
Capitalized R&D asset: 64954.75
ROCI (R&D-adjusted, %): -26.87263851220213
Rosenberg metric: 1.9502666666666666
FCF margin (%): -692.8867348817633
Revenue growth (%): 6.360597031628128
Rule of 40 score: -686.5261378501352
Financial ratios for ELAB — annual report dated 2025-12-31
Total revenue: 590084
Gross profit: 185314
Operating income: -6821330
Net income: -7747813
Capital expenditures: 442255
Operating cash flow: -5933881
Depreciation & amortization: 96663
Net tangible assets: 3967191
Owner earnings: -8093405
Return on net tangible assets (%): -204.00845333637832
Buffett classification: The Gruesome
Stock price: 35.52
Shares outstanding: 4543751
Book value: 7837362
P/B ratio: 20.592903009966875
Market cap (USD): 161394035.52
Debt to equity: 0.3374794988415745
Current ratio: 1.7429576571622223
Quick ratio: 1.7188351661062486
Interest coverage ratio: -26.47723479408454
COGS to revenue (%): 68.59531863260146
R&D to revenue (%): 24.91340215969252
SG&A to revenue (%): 954.4617376509107
Free cash flow (dilution-adjusted): -6362976
Buyback yield (%): 0.0001109086834735093
Retained earnings: -21017440
Inventory turnover: 4.256346085091169
Receivables turnover: 1.7328348960887554
Capitalized R&D asset: 219573.47999999998
ROCI (R&D-adjusted, %): -73.92152251238763
Rosenberg metric: 1.770730215758595
FCF margin (%): -1078.316985378353
Rule of 40 score: -1078.316985378353
Financial ratios for EZE.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.20454545454545453
Shares outstanding: 731729119
Market cap (USD): 149671865.25
Buyback yield (%): 0.31736091429514673
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EZE.MC — annual report dated 2022-12-31
Total revenue: 22969148.936170213
Gross profit: 18020212.76595745
Operating income: -15328723.40425532
Net income: -64325531.91489362
Capital expenditures: 3039361.7021276597
Operating cash flow: 9143617.021276597
Depreciation & amortization: 1726595.7446808512
Net tangible assets: -244114893.6170213
Owner earnings: -65638297.872340426
Buffett classification: The Gruesome
Stock price: 0.09574468085106383
Shares outstanding: 731729119
Book value: -219210638.29787236
Market cap (USD): 70059170.96808511
Debt to equity: -0.7389861107066942
Current ratio: 0.1510804147632514
Quick ratio: 0.13451526357769558
Interest coverage ratio: -30.788461538461537
COGS to revenue (%): 21.54601454309666
SG&A to revenue (%): 20.439071835487006
Free cash flow (dilution-adjusted): 6104255.319148936
Buyback yield (%): 0
Retained earnings: -64325531.91489362
Inventory turnover: 1.0181659006347124
Receivables turnover: 1.5073303546495391
Capitalized R&D asset: 0
FCF margin (%): 26.57588810152378
Rule of 40 score: 26.57588810152378
Financial ratios for EZE.MC — annual report dated 2023-12-31
Total revenue: 19196666.666666668
Gross profit: 15597777.777777778
Operating income: -12593333.333333332
Net income: 215706666.66666666
Capital expenditures: 20000
Operating cash flow: -24008888.888888888
Depreciation & amortization: 701111.1111111111
Net tangible assets: -6103333.333333333
Owner earnings: 216387777.77777776
Return on net tangible assets (%): -3545.4032404878935
Buffett classification: The Gruesome
Stock price: 0.09999999999999999
P/E ratio: 0.33922415579799725
Shares outstanding: 731729119
Book value: -5694444.444444444
Market cap (USD): 73172911.89999999
Debt to equity: -0.5500487804878049
Current ratio: 0.5995915501946518
Quick ratio: 0.5662773629459442
Effective tax rate (%): -0.7461690588563595
Interest coverage ratio: -492.78260869565213
COGS to revenue (%): 18.747467731666376
SG&A to revenue (%): 39.30080453782485
Free cash flow (dilution-adjusted): -24028888.888888888
Buyback yield (%): 0
Retained earnings: 215706666.66666666
Inventory turnover: 6.204980842911878
Receivables turnover: 5.672028890347998
Capitalized R&D asset: 0
FCF margin (%): -125.17219424668633
Revenue growth (%): -16.4241273370077
Rule of 40 score: -141.59632158369402
Financial ratios for EZE.MC — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -4075000
Buffett classification: The Gruesome
Stock price: 0.08333333333333334
Shares outstanding: 731729119
Book value: -3794791.666666668
Market cap (USD): 60977426.58333334
Debt to equity: -0.28602799890200375
Current ratio: 0.455050670153645
Quick ratio: 0.38389451890596055
Buyback yield (%): 0
Retained earnings: -1743750
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EZE.MC — annual report dated 2024-12-31
Total revenue: 14462500
Gross profit: 10589583.333333334
Operating income: -3078125
Net income: -1737500
Capital expenditures: 59375
Operating cash flow: -1194791.6666666667
Depreciation & amortization: 269791.6666666667
Net tangible assets: -4075000
Owner earnings: -1527083.3333333333
Buffett classification: The Gruesome
Stock price: 0.08333333333333334
Shares outstanding: 731729119
Book value: -3794791.666666668
Market cap (USD): 60977426.58333334
Debt to equity: -0.28602799890200375
Current ratio: 0.455050670153645
Quick ratio: 0.3747412008281573
Interest coverage ratio: -5.3629764065335745
COGS to revenue (%): 26.77902621722847
SG&A to revenue (%): 9.269662921348315
Free cash flow (dilution-adjusted): -1254166.6666666667
Buyback yield (%): 0
Retained earnings: -1743750
Inventory turnover: 5.044776119402985
Receivables turnover: 11.010309278350515
Capitalized R&D asset: 0
FCF margin (%): -8.671852492077212
Revenue growth (%): -24.661399548532735
Rule of 40 score: -33.33325204060995
Financial ratios for EZE.MC — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -15355294.11764706
Buffett classification: The Gruesome
Stock price: 0.1411764705882353
Shares outstanding: 731729119
Book value: 4122352.9411764666
P/B ratio: 25.059216404109613
Market cap (USD): 103302934.44705883
Debt to equity: 2.266837899543381
Current ratio: 0.9776892065237309
Quick ratio: 0.9299981674912956
Buyback yield (%): 0
Retained earnings: -77141176.47058824
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FF — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.4
Shares outstanding: 43863507
Market cap (USD): 192999430.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FF — annual report dated 2022-12-31
Total revenue: 396014000
Gross profit: 28993000
Operating income: 17546000
Net income: 15211000
Capital expenditures: 61000
Operating cash flow: 52451000
Depreciation & amortization: 10454000
Net tangible assets: 283000000
Owner earnings: 25604000
Return on net tangible assets (%): 9.047349823321554
Capex to operating income (%): 0.34765758577453554
Buffett classification: The Great
Stock price: 4.83
P/E ratio: 13.928126935112747
Shares outstanding: 43863507
Book value: 283000000
P/B ratio: 0.7486245187632509
Market cap (USD): 211860738.81
Debt to equity: 0.0022261484098939927
Current ratio: 4.880316588826696
Quick ratio: 4.276070448144319
Effective tax rate (%): -10.72208472849032
Interest coverage ratio: 137.078125
COGS to revenue (%): 92.678794184044
R&D to revenue (%): 0.8623432504911442
SG&A to revenue (%): 2.028211123849157
Free cash flow (dilution-adjusted): 47627000
Buyback yield (%): 0
Retained earnings: 508000
Inventory turnover: 10.827536360149866
Receivables turnover: 14.061499130064268
Capitalized R&D asset: 3415000
ROCI (R&D-adjusted, %): 6.535964952772851
FCF margin (%): 12.026595019368003
Rule of 40 score: 12.026595019368003
Financial ratios for FF — annual report dated 2023-12-31
Total revenue: 368250000
Gross profit: 40979000
Operating income: 27368000
Net income: 37382000
Capital expenditures: 0
Operating cash flow: 21299000
Depreciation & amortization: 10348000
Net tangible assets: 309880000
Owner earnings: 47730000
Return on net tangible assets (%): 15.402736543178005
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.73
P/E ratio: 4.376728936654004
Shares outstanding: 43863507
Book value: 309880000
P/B ratio: 0.5279814157415773
Market cap (USD): 163610881.10999998
Debt to equity: 0.0012553246417968246
Current ratio: 7.027525154798762
Quick ratio: 6.413578753869969
Effective tax rate (%): 0.002675012706310355
Interest coverage ratio: 198.31884057971016
COGS to revenue (%): 88.87196198234895
R&D to revenue (%): 1.1942973523421587
SG&A to revenue (%): 2.5018329938900203
Free cash flow (dilution-adjusted): 15277000
Buyback yield (%): 0
Retained earnings: 27387000
Inventory turnover: 12.893314423039042
Receivables turnover: 12.134642633538736
Capitalized R&D asset: 6686050
ROCI (R&D-adjusted, %): 8.772456262183583
Rosenberg metric: 3.509809663250366
FCF margin (%): 4.148540393754243
Revenue growth (%): -7.010863252309261
Rule of 40 score: -2.862322858555018
Financial ratios for FF — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.26
Shares outstanding: 43863507
Market cap (USD): 230722046.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FF — annual report dated 2024-12-31
Total revenue: 243339000
Gross profit: 19644000
Operating income: 6372000
Net income: 15503000
Capital expenditures: 6000
Operating cash flow: 24802000
Depreciation & amortization: 9208000
Net tangible assets: 205821000
Owner earnings: 24705000
Return on net tangible assets (%): 12.00314836678473
Capex to operating income (%): 0.09416195856873823
Buffett classification: The Great
Stock price: 4.89
P/E ratio: 13.835551133974068
Shares outstanding: 43863507
Book value: 205821000
P/B ratio: 1.0421315085924177
Market cap (USD): 214492549.23
Debt to equity: 0
Current ratio: 4.947488515927583
Quick ratio: 4.095535473023689
Effective tax rate (%): 4.860386621663086
Interest coverage ratio: 46.17391304347826
COGS to revenue (%): 91.92731128179207
R&D to revenue (%): 1.6409206908880203
SG&A to revenue (%): 3.8131988707112296
Free cash flow (dilution-adjusted): 9775000
Buyback yield (%): 0
Retained earnings: 383000
Inventory turnover: 7.883246405413025
Receivables turnover: 11.086564308168937
Capitalized R&D asset: 8066610
ROCI (R&D-adjusted, %): 2.8903794269958016
Rosenberg metric: -4.851068667576171
FCF margin (%): 4.017029740403306
Revenue growth (%): -33.92016293279023
Rule of 40 score: -29.90313319238692
Financial ratios for FF — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.89
Shares outstanding: 43863507
Market cap (USD): 214492549.23
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FF — quarterly report dated 2025-03-31
Total revenue: 17538000
Gross profit: -15188000
Operating income: -19463000
Net income: -18094000
Capital expenditures: 31000
Operating cash flow: -5395000
Depreciation & amortization: 2328000
Net tangible assets: 188404000
Owner earnings: -15797000
Return on net tangible assets (%): -8.384641515042143
Buffett classification: The Gruesome
Stock price: 3.66
Shares outstanding: 43863507
Book value: 188404000
P/B ratio: 0.8521073630071548
Market cap (USD): 160540435.62
Debt to equity: 0
Current ratio: 4.695343201467121
Quick ratio: 3.8010217448257793
Interest coverage ratio: -540.6388888888889
COGS to revenue (%): 186.6005245752081
R&D to revenue (%): 7.931349070589578
SG&A to revenue (%): 16.44429239365948
Free cash flow (dilution-adjusted): -9624000
Buyback yield (%): 0
Retained earnings: -17261000
Inventory turnover: 1.1983595151781463
Receivables turnover: 2.1991222570532916
Capitalized R&D asset: 1391000
ROCI (R&D-adjusted, %): -9.33673846319169
FCF margin (%): -54.87512829284981
Rule of 40 score: -54.87512829284981
Financial ratios for FF — quarterly report dated 2025-06-30
Total revenue: 35673000
Gross profit: -8767000
Operating income: -11928000
Net income: -10416000
Capital expenditures: 3000
Operating cash flow: 5212000
Depreciation & amortization: 2411000
Net tangible assets: 178224000
Owner earnings: -8008000
Return on net tangible assets (%): -4.493222012748003
Buffett classification: The Gruesome
Stock price: 3.69
Shares outstanding: 43863507
Book value: 178224000
P/B ratio: 0.9081624294707783
Market cap (USD): 161856340.82999998
Debt to equity: 0
Current ratio: 4.161446717734898
Quick ratio: 3.850512298393613
Interest coverage ratio: -458.7692307692308
COGS to revenue (%): 124.57600986740671
R&D to revenue (%): 2.6154234294844843
SG&A to revenue (%): 6.245619936646764
Free cash flow (dilution-adjusted): -499000
Buyback yield (%): 0
Retained earnings: -27678000
Inventory turnover: 4.61954261954262
Receivables turnover: 3.2441797017097125
Capitalized R&D asset: 1864970
ROCI (R&D-adjusted, %): -6.222794220888945
Rosenberg metric: 4.616103522645579
FCF margin (%): -1.398817032489558
Revenue growth (%): 103.40403694834075
Rule of 40 score: 102.00521991585119
Financial ratios for FF — quarterly report dated 2025-09-30
Total revenue: 22689000
Gross profit: -6831000
Operating income: -9735000
Net income: -9327000
Capital expenditures: 0
Operating cash flow: -1116000
Depreciation & amortization: 2404000
Net tangible assets: 169123000
Owner earnings: -6923000
Return on net tangible assets (%): -4.093470432761954
Buffett classification: The Gruesome
Stock price: 3.75
Shares outstanding: 43863507
Book value: 169123000
P/B ratio: 0.972594805260077
Market cap (USD): 164488151.25
Debt to equity: 0
Current ratio: 4.455195292445006
Quick ratio: 4.2129852691441885
Interest coverage ratio: -77.26190476190476
COGS to revenue (%): 130.1071003570012
R&D to revenue (%): 3.768345894486315
SG&A to revenue (%): 9.030807880470713
Free cash flow (dilution-adjusted): -6684000
Buyback yield (%): 0
Retained earnings: -37005000
Inventory turnover: 4.813305070927767
Receivables turnover: 2.865858279651383
Capitalized R&D asset: 1939140
ROCI (R&D-adjusted, %): -5.518660230160648
Rosenberg metric: 2.07502679528403
FCF margin (%): -29.45920930847547
Revenue growth (%): -36.39727525018922
Rule of 40 score: -65.85648455866469
Financial ratios for FF — annual report dated 2025-12-31
Total revenue: 95742000
Gross profit: -39425000
Operating income: -52990000
Net income: -49397000
Capital expenditures: 34000
Operating cash flow: -28735000
Depreciation & amortization: 9657000
Net tangible assets: 154708000
Owner earnings: -39774000
Return on net tangible assets (%): -25.70907774646431
Buffett classification: The Gruesome
Stock price: 3.14
Shares outstanding: 43863507
Book value: 154708000
P/B ratio: 0.89026690268118
Market cap (USD): 137731411.98000002
Debt to equity: 0
Current ratio: 5.667737934145241
Quick ratio: 3.9409675236806496
Interest coverage ratio: -346.33986928104576
COGS to revenue (%): 141.17837521672828
R&D to revenue (%): 4.037935284410186
SG&A to revenue (%): 10.130350316475528
Free cash flow (dilution-adjusted): -46990000
Buyback yield (%): 0
Retained earnings: -49067000
Inventory turnover: 4.4134722131522235
Receivables turnover: 7.881946159545567
Capitalized R&D asset: 7992650
ROCI (R&D-adjusted, %): -29.156197411140667
Rosenberg metric: -14.793137991485098
FCF margin (%): -49.07981867936746
Revenue growth (%): -60.65488885875261
Rule of 40 score: -109.73470753812006
Financial ratios for FF — quarterly report dated 2025-12-31
Total revenue: 19842000
Gross profit: -9264000
Operating income: -12489000
Net income: -12011000
Capital expenditures: 0
Operating cash flow: -27436000
Depreciation & amortization: 2514000
Net tangible assets: 154708000
Owner earnings: -9497000
Return on net tangible assets (%): -6.13866121984642
Buffett classification: The Gruesome
Stock price: 3.14
Shares outstanding: 43863507
Book value: 154708000
P/B ratio: 0.89026690268118
Market cap (USD): 137731411.98000002
Debt to equity: 0
Current ratio: 5.667737934145241
Quick ratio: 3.9409675236806496
COGS to revenue (%): 146.6888418506199
R&D to revenue (%): 3.4623525854248562
SG&A to revenue (%): 12.79104928938615
Free cash flow (dilution-adjusted): -30183000
Buyback yield (%): 0
Retained earnings: -49067000
Inventory turnover: 0.950368967543917
Receivables turnover: 1.6334897505556927
Capitalized R&D asset: 1567740
ROCI (R&D-adjusted, %): -7.171427153191612
Rosenberg metric: -2.8456140350877193
FCF margin (%): -152.11672210462655
Revenue growth (%): -12.547930715324608
Rule of 40 score: -164.66465281995116
Financial ratios for FILATEX.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.8234208097059211
Shares outstanding: 444058375
Market cap (USD): 365646906.69919556
Buyback yield (%): 0
Retained earnings: 116132651.98470263
Capitalized R&D asset: 79955.16286430173
Rule of 40 score: 0
Financial ratios for FILATEX.NS — annual report dated 2023-03-31
Total revenue: 522574214.37271625
Gross profit: 47292168.08769793
Operating income: 20143568.818514008
Net income: 10949524.96954933
Capital expenditures: 13593520.097442145
Operating cash flow: 39637734.470158346
Depreciation & amortization: 8362277.710109623
Net tangible assets: 133803154.68940318
Owner earnings: 5718282.582216809
Return on net tangible assets (%): 4.273653035678149
Capex to operating income (%): 67.48317649128938
Buffett classification: The Good
Stock price: 0.3861144945188794
P/E ratio: 15.658887072893444
Shares outstanding: 444058375
Book value: 133863325.2131547
P/B ratio: 1.2808390552601554
Market cap (USD): 171457375
Debt to equity: 0.27616456474457785
Current ratio: 1.2740595459933444
Quick ratio: 0.5715194811548698
Effective tax rate (%): 26.363730191365377
Interest coverage ratio: 4.764762148971295
COGS to revenue (%): 90.95015276548497
R&D to revenue (%): 0.0273731583107638
SG&A to revenue (%): 1.4829939941976082
Free cash flow (dilution-adjusted): 25974384.896467723
Buyback yield (%): 4.226857806325143
Retained earnings: 115835115.71254568
Inventory turnover: 9.53474920268161
Receivables turnover: 32.731828956332734
Capitalized R&D asset: 196615.02611055598
ROCI (R&D-adjusted, %): 10.82988235022494
FCF margin (%): 4.970468152097145
Rule of 40 score: 4.970468152097145
Financial ratios for FILATEX.NS — annual report dated 2024-03-31
Total revenue: 512839081.42463124
Gross profit: 49055594.19594675
Operating income: 20186892.91281928
Net income: 13270164.288283966
Capital expenditures: 8324415.397529679
Operating cash flow: 20130171.483391292
Depreciation & amortization: 8695826.83775033
Net tangible assets: 144355726.10624775
Owner earnings: 13641575.728504617
Return on net tangible assets (%): 9.449972021521498
Capex to operating income (%): 41.23673431805558
Buffett classification: The Good
Stock price: 0.6970969289827256
P/E ratio: 23.326895038884953
Shares outstanding: 444058375
Book value: 144392301.23516008
P/B ratio: 2.143824337264475
Market cap (USD): 309551729.5015595
Debt to equity: 0.1933800652676874
Current ratio: 1.4429118552259994
Quick ratio: 0.6153004011372293
Effective tax rate (%): 26.438394592625485
Interest coverage ratio: 9.242867653518404
COGS to revenue (%): 90.43450548665797
R&D to revenue (%): 0.04351857054625451
SG&A to revenue (%): 1.4846120312771576
Free cash flow (dilution-adjusted): 11692852.860055162
Buyback yield (%): 0
Retained earnings: 126514977.81508574
Inventory turnover: 9.259753051895208
Receivables turnover: 35.91380063252339
Capitalized R&D asset: 345405.6360680488
ROCI (R&D-adjusted, %): 10.587331088132812
Rosenberg metric: 12.327765964511949
FCF margin (%): 2.2800237508368575
Revenue growth (%): -1.8629187358145476
Rule of 40 score: 0.4171050150223099
Financial ratios for FILATEX.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 148168896.32107022
Buffett classification: The Gruesome
Stock price: 0.7323220258002867
Shares outstanding: 444058375
Book value: 148306258.95843288
P/B ratio: 2.192717495791788
Market cap (USD): 325193728.7535834
Debt to equity: 0.17746975725262157
Current ratio: 1.3133225475249681
Quick ratio: 0.5212034473102889
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FILATEX.NS — quarterly report dated 2025-03-31
Total revenue: 126259060.08884731
Gross profit: 23101472.995090015
Operating income: 6650689.735796118
Net income: 4803600.654664484
Capital expenditures: 0
Depreciation & amortization: 2197802.1978021977
Net tangible assets: 155332417.58241758
Owner earnings: 7001402.852466682
Return on net tangible assets (%): 4.507367464844754
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.4383241918543588
P/E ratio: 10.129980734817655
Shares outstanding: 444058375
Book value: 155522013.09328967
P/B ratio: 1.2515368370474944
Market cap (USD): 194641528.3580348
Debt to equity: 0.11061872897757431
Current ratio: 1.4024313305966485
Quick ratio: 0.6776187391276385
Effective tax rate (%): 25.830324909747294
Interest coverage ratio: 7.615796519410977
COGS to revenue (%): 81.70311660895169
Buyback yield (%): 0
Retained earnings: 137918611.17605796
Inventory turnover: 1.9096642110821596
Receivables turnover: 8.44710645034132
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4735271014793163
Rule of 40 score: 0
Financial ratios for FILATEX.NS — annual report dated 2025-03-31
Total revenue: 497094926.3502455
Gross profit: 87711012.39186345
Operating income: 21545475.800794948
Net income: 15648819.265840542
Capital expenditures: 6046294.131400514
Operating cash flow: 36527940.14496142
Depreciation & amortization: 8573766.658873042
Net tangible assets: 155332417.58241758
Owner earnings: 18176291.793313067
Return on net tangible assets (%): 11.701544388613495
Capex to operating income (%): 28.062940857297885
Buffett classification: The Good
Stock price: 0.4383241918543588
P/E ratio: 12.438096769569922
Shares outstanding: 444058375
Book value: 155522013.09328967
P/B ratio: 1.2515368370474944
Market cap (USD): 194641528.3580348
Debt to equity: 0.11061872897757431
Current ratio: 1.4024313305966485
Quick ratio: 0.6776187391276385
Effective tax rate (%): 25.426183844011142
Interest coverage ratio: 8.520573277854831
COGS to revenue (%): 82.35527909410533
SG&A to revenue (%): 1.4795809178885975
Free cash flow (dilution-adjusted): 30240823.006780453
Buyback yield (%): 0
Retained earnings: 137918611.17605796
Inventory turnover: 7.578558505527229
Receivables turnover: 33.257128287271385
Capitalized R&D asset: 196735.63119100936
ROCI (R&D-adjusted, %): 11.177544328391958
Rosenberg metric: 173.20269321140688
FCF margin (%): 6.083510694589796
Revenue growth (%): -3.0699990785900315
Rule of 40 score: 3.0135116159997644
Financial ratios for FILATEX.NS — quarterly report dated 2025-06-30
Total revenue: 122794289.7261877
Gross profit: 23722209.22068804
Operating income: 6882752.164755441
Net income: 4757781.418207349
Capital expenditures: 0
Depreciation & amortization: 2212731.102270068
Owner earnings: 6970512.520477418
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6432249005382635
P/E ratio: 15.008539642000736
Shares outstanding: 444058375
Market cap (USD): 285629404.0925579
Effective tax rate (%): 25.829989055089385
Interest coverage ratio: 12.053278688524589
COGS to revenue (%): 80.68134171907757
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.7441756339873566
Rule of 40 score: -2.7441756339873566
Financial ratios for FILATEX.NS — quarterly report dated 2025-09-30
Total revenue: 121299887.26042841
Gross profit: 24404735.062006764
Operating income: 7832018.038331454
Net income: 5360766.629086809
Capital expenditures: 0
Depreciation & amortization: 2193912.06313416
Net tangible assets: 158490417.1364149
Owner earnings: 7554678.692220969
Return on net tangible assets (%): 4.766646986434867
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5762119503945885
P/E ratio: 17.14711114721813
Shares outstanding: 444058375
Book value: 158749718.151071
P/B ratio: 1.6117933645986466
Market cap (USD): 255871742.34780157
Debt to equity: 0.09978623829104262
Current ratio: 1.382045899407109
Quick ratio: 0.818742730702675
Effective tax rate (%): 25.423462986198242
Interest coverage ratio: 14.563941299790354
COGS to revenue (%): 79.88066138131661
Buyback yield (%): 0
Inventory turnover: 2.1641234829027547
Receivables turnover: 8.122065373292067
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.081716588914089
Revenue growth (%): -1.2169967097750056
Rule of 40 score: -1.2169967097750056
Financial ratios for FILATEX.NS — quarterly report dated 2025-12-31
Total revenue: 116932159.96435335
Gross profit: 24314358.91723293
Operating income: 8216553.414280941
Net income: 6122312.5765846055
Capital expenditures: 0
Depreciation & amortization: 2186699.3427648437
Owner earnings: 8309011.919349449
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5442798262225688
P/E ratio: 11.484827859390412
Shares outstanding: 444058375
Market cap (USD): 241692015.17767626
Effective tax rate (%): 25.508267823258336
Interest coverage ratio: 16.282560706401767
COGS to revenue (%): 79.20643993521959
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.6007678116778776
Rule of 40 score: -3.6007678116778776
Financial ratios for GNM.AX — annual report dated 2021-06-30
Capital expenditures: 3290.9774436090224
Buffett classification: The Gruesome
Stock price: 0.12030075187969924
Shares outstanding: 493613693
Market cap (USD): 59382098.40601503
Buyback yield (%): 0.4975094967634945
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GNM.AX — annual report dated 2022-06-30
Operating income: -4778033.103448276
Net income: -4776128.9655172415
Capital expenditures: 0
Depreciation & amortization: 28838.620689655174
Net tangible assets: 440119.3103448276
Owner earnings: -4747290.344827587
Return on net tangible assets (%): -1078.6371407126283
Buffett classification: The Gruesome
Stock price: 0.041379310344827586
Shares outstanding: 493613693
Book value: -405808.27586206887
Market cap (USD): 20425394.193103448
Debt to equity: -0.07645533307728129
Current ratio: 0.6250838821089745
Quick ratio: 0.6250838821089745
Free cash flow (dilution-adjusted): -1349633.103448276
Buyback yield (%): 0.5302392073903294
Retained earnings: -59590031.03448276
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -422.099302101008
Rule of 40 score: 0
Financial ratios for GNM.AX — annual report dated 2023-06-30
Operating income: -1977176.821192053
Net income: 908437.0860927153
Capital expenditures: 11755.629139072847
Depreciation & amortization: 27239.735099337748
Net tangible assets: 2374782.119205298
Owner earnings: 923921.1920529802
Return on net tangible assets (%): 38.905514092474434
Buffett classification: The Gruesome
Stock price: 0.019867549668874173
P/E ratio: 10.79534809074606
Shares outstanding: 493613693
Book value: 1567691.390728477
P/B ratio: 6.2556282575212885
Market cap (USD): 9806894.562913908
Debt to equity: 0.004929845801858217
Current ratio: 9.110741089146302
Quick ratio: 9.110741089146302
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -1885320.5298013245
Buyback yield (%): 0.5679475076204312
Retained earnings: -56245372.84768212
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.11073813354874
Rule of 40 score: 0
Financial ratios for GNM.AX — annual report dated 2024-06-30
Operating income: -1018688.6666666666
Net income: -973656
Capital expenditures: 7738.666666666667
Depreciation & amortization: 15581.333333333334
Net tangible assets: 1647482.6666666667
Owner earnings: -965813.3333333333
Return on net tangible assets (%): -58.62358086519068
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 493613693
Book value: 945265.3333333333
P/B ratio: 3.4813060812554926
Market cap (USD): 3290757.9533333336
Debt to equity: 0
Current ratio: 3.1660118402104924
Quick ratio: 3.1660118402104924
Interest coverage ratio: -4244.536111111111
Free cash flow (dilution-adjusted): -1046347.3333333334
Buyback yield (%): 0
Retained earnings: -57370918.666666664
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -42.02504066274918
Rule of 40 score: 0
Financial ratios for HAUTO.OL — annual report dated 2021-12-31
Operating income: 18810000
Capital expenditures: 0
Depreciation & amortization: 15279659.09090909
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.9714937286202965
Shares outstanding: 190769288
Market cap (USD): 185331166.90535918
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HAUTO.OL — annual report dated 2022-12-31
Total revenue: 128574898.7854251
Gross profit: 31623886.639676113
Operating income: 29882894.736842103
Net income: 30221153.846153844
Capital expenditures: 10484817.813765181
Operating cash flow: 41032894.7368421
Depreciation & amortization: 15330971.659919027
Net tangible assets: 107588360.32388663
Owner earnings: 35067307.69230769
Return on net tangible assets (%): 32.593960523926754
Capex to operating income (%): 35.08635259769072
Buffett classification: The Good
Stock price: 2.5232793522267203
P/E ratio: 15.928055159636283
Shares outstanding: 190769288
Book value: 107588360.32388663
P/B ratio: 4.474129022882049
Market cap (USD): 481364205.4493926
Debt to equity: 0.5299400831441626
Current ratio: 1.130904687770282
Quick ratio: 0.9655353745026812
Effective tax rate (%): 4.780643988557834
Interest coverage ratio: 9.452313110292941
COGS to revenue (%): 75.40430757604383
SG&A to revenue (%): 0.4354021034070155
Free cash flow (dilution-adjusted): 27301315.789473683
Buyback yield (%): 0
Retained earnings: 33318522.267206475
Inventory turnover: 20.039246861924685
Receivables turnover: 14.74304814075484
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.17876658166665
FCF margin (%): 21.233783613577682
Rule of 40 score: 21.233783613577682
Financial ratios for HAUTO.OL — annual report dated 2023-12-31
Total revenue: 142050589.3909627
Gross profit: 59821119.84282908
Operating income: 57951277.01375246
Net income: 57916011.78781925
Capital expenditures: 11368074.656188605
Operating cash flow: 73306090.37328094
Depreciation & amortization: 14299115.913555993
Net tangible assets: 138676719.05697447
Owner earnings: 60847053.04518664
Return on net tangible assets (%): 43.87690555340295
Capex to operating income (%): 19.616607678016894
Buffett classification: The Great
Stock price: 4.213163064833006
P/E ratio: 13.877718670454644
Shares outstanding: 190769288
Book value: 138676719.05697447
P/B ratio: 5.795797042010188
Market cap (USD): 803742118.1060904
Debt to equity: 0.3611507591046157
Current ratio: 2.5874232326052065
Quick ratio: 2.398052027357108
Effective tax rate (%): 1.3845958278136834
Interest coverage ratio: 17.695311796994513
COGS to revenue (%): 57.88745397022975
SG&A to revenue (%): 0.4943726985114879
Free cash flow (dilution-adjusted): 55800196.46365423
Buyback yield (%): 0
Retained earnings: 66540275.04911592
Inventory turnover: 19.280818131564402
Receivables turnover: 17.986678607410727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 32.2359678265431
FCF margin (%): 39.281918296077315
Revenue growth (%): 10.480809810340027
Rule of 40 score: 49.76272810641734
Financial ratios for HAUTO.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.357824427480915
Shares outstanding: 190769288
Market cap (USD): 1594416215.259542
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HAUTO.OL — quarterly report dated 2024-12-31
Total revenue: 31097969.991173875
Gross profit: 13454457.193292145
Operating income: 12804942.630185349
Net income: 12193733.451015005
Capital expenditures: 21480052.956751987
Operating cash flow: 16230626.6548985
Depreciation & amortization: 2969020.3000882613
Net tangible assets: 103923124.44836716
Owner earnings: -6317299.20564872
Return on net tangible assets (%): -6.078819549721475
Capex to operating income (%): 167.7481389578164
Buffett classification: The Gruesome
Stock price: 7.23015873015873
P/E ratio: 28.27871050774349
Shares outstanding: 190769288
Book value: 103923124.44836718
P/B ratio: 13.27223599560508
Market cap (USD): 1379292233.079365
Debt to equity: 0.6697597942670976
Current ratio: 1.6954786272458626
Quick ratio: 1.5029141377864121
Effective tax rate (%): 1.4501954518218392
Interest coverage ratio: 16.869767441860464
COGS to revenue (%): 56.73525571890787
SG&A to revenue (%): 2.088607594936709
Free cash flow (dilution-adjusted): -5270962.047661076
Buyback yield (%): 0.025109773670980648
Retained earnings: 50391438.65842895
Inventory turnover: 5.004406058330204
Receivables turnover: 4.141376148945674
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.643002054043631
FCF margin (%): -16.94953737866833
Rule of 40 score: -16.94953737866833
Financial ratios for HAUTO.OL — annual report dated 2024-12-31
Total revenue: 120990997.3521624
Gross profit: 51472992.0564872
Operating income: 49439541.04148279
Net income: 54678640.77669903
Capital expenditures: 26219505.736981466
Operating cash flow: 62459223.300970875
Depreciation & amortization: 11643601.05913504
Net tangible assets: 103923124.44836716
Owner earnings: 40102736.098852605
Return on net tangible assets (%): 38.58884758490602
Capex to operating income (%): 53.03347317682764
Buffett classification: The Good
Stock price: 7.23015873015873
P/E ratio: 25.225430140303377
Shares outstanding: 190769288
Book value: 103923124.44836718
P/B ratio: 13.27223599560508
Market cap (USD): 1379292233.079365
Debt to equity: 0.6697597942670976
Current ratio: 1.6954786272458626
Quick ratio: 1.5029141377864121
Effective tax rate (%): -6.09320653709612
Interest coverage ratio: 20.940186915887853
COGS to revenue (%): 57.457171869848
SG&A to revenue (%): 0.719492160942146
Free cash flow (dilution-adjusted): 25662488.967343338
Buyback yield (%): 0.025109773670980648
Retained earnings: 50391438.65842895
Inventory turnover: 19.718087370133937
Receivables turnover: 16.112602552951408
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.509426527243864
FCF margin (%): 21.210246653847165
Revenue growth (%): -14.825416866689961
Rule of 40 score: 6.384829787157203
Financial ratios for HAUTO.OL — quarterly report dated 2025-03-31
Total revenue: 31417175.572519083
Gross profit: 12024904.580152672
Operating income: 11427767.175572518
Net income: 14760591.603053434
Capital expenditures: 2601240.4580152673
Operating cash flow: 11551335.877862595
Depreciation & amortization: 3324332.061068702
Net tangible assets: 118565076.33587785
Owner earnings: 15483683.206106868
Return on net tangible assets (%): 13.059227628078116
Capex to operating income (%): 22.762455850304352
Buffett classification: The Great
Stock price: 5.6288167938931295
P/E ratio: 18.187031403119768
Shares outstanding: 190769288
Book value: 118565076.33587785
P/B ratio: 9.056675078684204
Market cap (USD): 1073805372.053435
Debt to equity: 0.6118221867399776
Current ratio: 1.8327197054586204
Quick ratio: 1.6162299080029003
Effective tax rate (%): 0.35492972262660877
Interest coverage ratio: 13.00923310884206
COGS to revenue (%): 61.725061654902625
SG&A to revenue (%): 1.9006718258355302
Free cash flow (dilution-adjusted): 8350286.259541985
Buyback yield (%): 0
Retained earnings: 60685687.02290076
Inventory turnover: 4.419794702274803
Receivables turnover: 3.2082708085670295
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.275650081535295
FCF margin (%): 26.578729969749617
Revenue growth (%): 1.0264515061137558
Rule of 40 score: 27.605181475863372
Financial ratios for HAUTO.OL — quarterly report dated 2025-06-30
Total revenue: 36488778.55014896
Gross profit: 13777060.575968223
Operating income: 13188182.720953327
Net income: 12221549.155908639
Capital expenditures: 14922542.204568023
Operating cash flow: 15202383.316782521
Depreciation & amortization: 3277656.405163853
Net tangible assets: 119953128.10327706
Owner earnings: 576663.3565044682
Return on net tangible assets (%): 0.48074057394149283
Capex to operating income (%): 113.15086028387485
Buffett classification: The Gruesome
Stock price: 7.594836146971201
P/E ratio: 36.98351379394036
Shares outstanding: 190769288
Book value: 119953128.10327706
P/B ratio: 12.078563578491433
Market cap (USD): 1448861484.2343595
Debt to equity: 0.7434524243166811
Current ratio: 1.790398533857982
Quick ratio: 1.5704870316014365
Effective tax rate (%): 0.777999935502596
Interest coverage ratio: 12.800481927710845
COGS to revenue (%): 62.24302066720735
SG&A to revenue (%): 1.613860146635387
Free cash flow (dilution-adjusted): 279841.1122144985
Buyback yield (%): 0
Retained earnings: 59711022.84011916
Inventory turnover: 5.096194126297965
Receivables turnover: 3.6281251234250957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.594546495512849
FCF margin (%): 0.7669237593960407
Revenue growth (%): 16.142771860326157
Rule of 40 score: 16.909695619722196
Financial ratios for HAUTO.OL — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.82064128256513
P/E ratio: 47.82220647168688
Shares outstanding: 190769288
Market cap (USD): 1873476745.178357
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HAUTO.OL — quarterly report dated 2025-12-31
Total revenue: 35656716.41791044
Gross profit: 12027860.696517412
Operating income: 11397810.94527363
Net income: 10402189.054726368
Capital expenditures: 7095422.885572139
Operating cash flow: 13550248.756218905
Depreciation & amortization: 3031144.2786069647
Net tangible assets: 126845572.13930348
Owner earnings: 6337910.447761193
Return on net tangible assets (%): 4.996556317157698
Capex to operating income (%): 62.252505499877785
Buffett classification: The Good
Stock price: 9.10358565737052
P/E ratio: 46.45487996598219
Shares outstanding: 190769288
Book value: 126845572.13930346
P/B ratio: 13.691329739096737
Market cap (USD): 1736684554.103586
Debt to equity: 0.7291343412838741
Current ratio: 2.5048264464583703
Quick ratio: 2.2925862133723958
Effective tax rate (%): -0.5375878749410962
Interest coverage ratio: 10.067498681666374
COGS to revenue (%): 66.26761545974607
SG&A to revenue (%): 1.7669875819729317
Free cash flow (dilution-adjusted): 6435422.885572139
Buyback yield (%): 0.005637779614602024
Retained earnings: 66500597.01492537
Inventory turnover: 6.003539375553028
Receivables turnover: 3.5104475857407347
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.335648671095185
FCF margin (%): 18.048276824333755
Rule of 40 score: 18.048276824333755
Financial ratios for HAUTO.OL — annual report dated 2025-12-31
Total revenue: 141841990.04975122
Gross profit: 51136417.910447754
Operating income: 48739800.995024875
Net income: 51092437.81094527
Capital expenditures: 17881691.542288557
Operating cash flow: 58057412.93532338
Depreciation & amortization: 13008557.213930348
Net tangible assets: 126845572.13930348
Owner earnings: 46219303.48258706
Return on net tangible assets (%): 36.437459111168984
Capex to operating income (%): 36.688068431206425
Buffett classification: The Good
Stock price: 9.10358565737052
P/E ratio: 33.991029367785316
Shares outstanding: 190769288
Book value: 126845572.13930346
P/B ratio: 13.691329739096737
Market cap (USD): 1736684554.103586
Debt to equity: 0.7291343412838741
Current ratio: 2.5048264464583703
Quick ratio: 2.2925862133723958
Effective tax rate (%): 0.4094338524796835
Interest coverage ratio: 11.399199460100998
COGS to revenue (%): 63.948321725808
SG&A to revenue (%): 0.6422955401287398
Free cash flow (dilution-adjusted): 29921592.039800994
Buyback yield (%): 0.005637779614602024
Retained earnings: 66500597.01492537
Inventory turnover: 23.04616356971306
Receivables turnover: 13.964518372664843
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.816526406448915
FCF margin (%): 21.095017088596943
Revenue growth (%): 17.233507578170368
Rule of 40 score: 38.32852466676731
Financial ratios for HHS — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 2559000
Buffett classification: The Gruesome
Stock price: 7.6
Shares outstanding: 7419470
Market cap (USD): 56387972
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HHS — annual report dated 2022-12-31
Total revenue: 206278000
Gross profit: 144348000
Operating income: 15107000
Net income: 36776000
Capital expenditures: 5743000
Operating cash flow: 28792000
Depreciation & amortization: 2728000
Net tangible assets: 12870000
Owner earnings: 33761000
Return on net tangible assets (%): 262.32323232323233
Capex to operating income (%): 38.015489508175015
Buffett classification: The Good
Stock price: 11.69
P/E ratio: 2.35842952740918
Shares outstanding: 7419470
Book value: 18808000
P/B ratio: 4.611527238409187
Market cap (USD): 86733604.3
Debt to equity: 1.1868353891960868
Current ratio: 1.5220814396547766
Quick ratio: 1.5220814396547766
Effective tax rate (%): -90.42095997514627
Interest coverage ratio: 34.490867579908674
COGS to revenue (%): 30.022590872511852
SG&A to revenue (%): 61.33131017364916
Free cash flow (dilution-adjusted): 20637000
Buyback yield (%): 12.100269652923902
Retained earnings: 846490000
Receivables turnover: 3.954413005137643
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.76890261456725
FCF margin (%): 10.004460000581739
Rule of 40 score: 10.004460000581739
Financial ratios for HHS — annual report dated 2023-12-31
Total revenue: 191492000
Gross profit: 131924000
Operating income: 9046000
Net income: -1570000
Capital expenditures: 2809000
Operating cash flow: 10477000
Depreciation & amortization: 4237000
Net tangible assets: 15111000
Owner earnings: -142000
Return on net tangible assets (%): -0.9397127920058236
Capex to operating income (%): 31.052398850320586
Buffett classification: The Good
Stock price: 6.79
Shares outstanding: 7419470
Book value: 19857000
P/B ratio: 2.537049972301959
Market cap (USD): 50378201.3
Debt to equity: 1.4355642846351413
Current ratio: 1.3554696431169586
Quick ratio: 1.3554696431169586
COGS to revenue (%): 31.107304743801308
SG&A to revenue (%): 61.9561130491091
Free cash flow (dilution-adjusted): 6247000
Buyback yield (%): 5.976791394495461
Retained earnings: 844920000
Receivables turnover: 4.351497523065037
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.11853280818798
FCF margin (%): 3.2622772752908737
Revenue growth (%): -7.1679965871299895
Rule of 40 score: -3.905719311839116
Financial ratios for HHS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.44
Shares outstanding: 7419470
Market cap (USD): 55200856.800000004
Buyback yield (%): 0.29528527173150687
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HHS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.15
Shares outstanding: 7419470
Market cap (USD): 38210270.5
Buyback yield (%): 0.03925646116532988
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HHS — annual report dated 2024-12-31
Total revenue: 185242000
Gross profit: 128598000
Operating income: 7663000
Net income: -30297000
Capital expenditures: 3744000
Operating cash flow: -2987000
Depreciation & amortization: 4385000
Net tangible assets: 20831000
Owner earnings: -29656000
Return on net tangible assets (%): -142.36474485142335
Capex to operating income (%): 48.85814954978468
Buffett classification: The Good
Stock price: 5.15
Shares outstanding: 7419470
Book value: 21689000
P/B ratio: 1.7617350039190374
Market cap (USD): 38210270.5
Debt to equity: 1.134031075660473
Current ratio: 1.5258559353388166
Quick ratio: 1.5258559353388166
COGS to revenue (%): 30.5783785534598
SG&A to revenue (%): 62.917696850606234
Free cash flow (dilution-adjusted): -8664000
Buyback yield (%): 0.7720437362514877
Retained earnings: 814623000
Receivables turnover: 4.540133820249504
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.498236927001274
FCF margin (%): -4.677125058032196
Revenue growth (%): -3.263843920372653
Rule of 40 score: -7.9409689784048485
Financial ratios for HHS — quarterly report dated 2025-03-31
Total revenue: 41561000
Gross profit: 27504000
Operating income: 798000
Net income: -392000
Capital expenditures: 103000
Operating cash flow: -818000
Depreciation & amortization: 1063000
Net tangible assets: 20612000
Owner earnings: 568000
Capex to operating income (%): 12.907268170426065
Buffett classification: The Great
Stock price: 4.8
Shares outstanding: 7419470
Book value: 21421000
P/B ratio: 1.662548713878904
Market cap (USD): 35613456
Debt to equity: 1.1097987955744364
Current ratio: 1.4884313779822107
Quick ratio: 1.4884313779822107
Interest coverage ratio: 15.056603773584905
COGS to revenue (%): 33.82257404778518
SG&A to revenue (%): 61.699670364043214
Free cash flow (dilution-adjusted): -874000
Buyback yield (%): 0
Retained earnings: 814231000
Receivables turnover: 1.0063683471354545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2372860332423716
FCF margin (%): -2.102933038184837
Rule of 40 score: -2.102933038184837
Financial ratios for HHS — quarterly report dated 2025-06-30
Total revenue: 38631000
Gross profit: 26231000
Operating income: 183000
Net income: -335000
Capital expenditures: 223000
Operating cash flow: -4850000
Depreciation & amortization: 1065000
Net tangible assets: 21479000
Owner earnings: 507000
Capex to operating income (%): 121.85792349726776
Buffett classification: The Gruesome
Stock price: 3.98
Shares outstanding: 7419470
Book value: 22240000
P/B ratio: 1.3277648651079137
Market cap (USD): 29529490.6
Debt to equity: 1.0218075539568345
Current ratio: 1.6014926807392933
Quick ratio: 1.6014926807392933
COGS to revenue (%): 32.09857368434677
SG&A to revenue (%): 64.67086019000284
Free cash flow (dilution-adjusted): -5293000
Buyback yield (%): 0
Retained earnings: 813896000
Receivables turnover: 0.9292999759441906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.28685184024076743
FCF margin (%): -13.701431492842536
Revenue growth (%): -7.049878491855345
Rule of 40 score: -20.751309984697883